Biomobie Technology
[Report for Studies on the Health Benefits of Pulsed Electromagnetic Field Therapy using Bioboosti]

Biomobie Partner Mayo Clinic Breakthrough in Study of Microcirculation in Heart Disease and Aging


High-tech medical interventions have been increasingly important in cutting edge solutions to age-old problems and chronic diseases related to aging. A recent study at the Mayo Clinic revealed that Biomobie’s Pulsed Electro-Magnetic Field (PEMF) therapy has been demonstrated to increase microcirculation which in turn appears to rebuild and normalize the circulatory system reversing the effects of chronic diseases among the aging population.


Health Problems Related to Aging


According to the World Health Organization (WHO) in 2010, an estimated 524 million people were aged 65 or older—8% of the world’s population. By 2050, this number is expected to nearly triple to about 1.5 billion, representing 16% of the world’s population. One of the major epidemiologic trends of the current century is the rise of chronic and degenerative diseases in countries throughout the world as the population ages in numbers humans have never seen before. Over the next 10 to 15 years, people in every world region will suffer more death and disability from such chronic diseases as heart disease, cancer, and diabetes than from infectious diseases.


Microcirculation Key to Normalizing Circulation


Scientists at the Mayo Clinic say that the first part of the body’s vital function that tends to degenerate with age is the microcirculatory system. While circulation refers to blood flow to and from vital organs, microcirculation refers to blood flow in the smallest blood vessels in the body – capillaries, arterioles, and other such blood vessels. These blood vessels are often embedded in the organs, including the skin, and interact directly with muscle tissue. Impaired microcirculatory problems have been shown to occur in certain chronic disease states including peripheral vascular disease, diabetes, high cholesterol, high blood pressure, chronic renal failure, and venous insufficiency, as well as in menopause, advanced age, and obesity. Poor microcirculation is one of the single biggest contributing factors to almost all health problems: diabetes, hypertension, vascular disease, atherosclerosis, kidney disease, Alzheimer’s, early aging and others. It is estimated that 80% of the population over the age of 40 may have moderately to extremely serious microcirculation problems.

Microcirculation appears to have an effect on a wide range of health problems that we call “chronic diseases.” Noncommunicable - or chronic diseases are diseases of long duration and generally slow progression. The four main types of noncommunicable diseases are cardiovascular diseases (like heart attacks and stroke), cancer, chronic respiratory diseases (such as chronic obstructed pulmonary disease and asthma) and diabetes. Chronic diseases are responsible for 7 of 10 deaths each year and treating people with chronic diseases accounts for most of our nation’s health care costs. 1 in 2 adults in America has chronic disease. 1 in 4 have 2 chronic diseases. These chronic diseases are by far the leading cause of death in the world, representing 63% of all annual deaths. Noncommunicable diseases (NCDs) kill more than 36 million people each year.

With this in mind, researchers at the world-famous Mayo Clinic conducted a clinical trial using Biomobie’s “Bioboosti,” a handheld device that emits a pulsed electro-magnetic field (PEMF), in order to test the efficacy of the device to enhance microcirculation. What they discovered is that daily “Bioboosti” therapy does aid in normalizing microcirculation in individual and in case studies. Biomobie is currently working in collaboration with the Mayo Clinic in order to determine what connections there may be between improved microcirculation and the use of Bioboosti.


If microcirculation is so critical to all bodily functions including the heart, brain, and all organ functioning, what is the connection between microcirculation and chronic diseases which affect all these critical organs? These two things, microcirculation and chronic diseases have been shown to be closely related, especially in the elderly population. What can medical researchers discover as the link connecting these things? What is the cause of the dysfunction of microcirculation? This is an area of critical concern in an era of such massive chronic diseases, with further research needing to be done.


The Biomobie technological breakthrough promises to be the third most effective new treatment to curb the "epidemic" of chronic diseases after medicine and vaccines, quietly repeating the history of smallpox conquest.







根據世界衛生組織(WHO)2010 年的統計,65 歲或以上人口約有 5.24 億人 - 占世界總人口的 8%。到 2050 年,這一數字預計將增至近 3 倍,約 15 億,占全球總人口的 16%。本世紀的主要流行病學趨勢之一是世界各國的慢性和退行性疾病的增加,這一趨勢與老齡化人口數量的大量增長都是前所未有的。在接下來的 10 至 15 年間,慢性疾病如心臟病、腦卒中、高血壓和糖尿病等導致的死亡率和致殘率將遠高于傳染性疾病。


循環系統正常化的關鍵 -- 微循環正常化


梅奧診所科學家認為,首先隨年齡增長而退化的機體重要功能是微循環系統功能。血液循環是指血液在血管內循環往復流動,而微循環則是指微動脈和微靜脈之間的血液循環。這些微血管在機體內無處不在,為各個組織器官供血供氧。微循環障礙是造成幾乎所有健康問題的最主要因素之一,如糖尿病、高血壓、血管疾病、高膽固醇、腎臟疾病、阿爾茨海默病、早衰、肥胖癥等。據估計,40 歲以上人群中有 80%可能有中重度微循環障礙。微循環似乎對慢性疾病都能產生一定的影響。 慢性疾病是指持續時間長,病情進展緩慢的疾病。主要有以下四種類型:心血管疾病(如心臟病和中風)、癌癥、慢性呼吸系統疾病(如慢性阻塞性肺病和哮喘)和糖尿病。 慢性病患者死亡人數占美國總死亡人數的 70%以上,其治療費用占美國國家醫療保健成本的大部分。 美國成年人中有 1/2 患有一種慢性病,1/4 同時患有兩種慢性病。而這些慢性病是迄今為止世界上人口死亡的主要原因,占全年死亡人數的 63%,慢性疾病每年造成超過 3600 萬人死亡。 微循環對各個組織器官的機能如此重要,且微循環和慢性病密切相關,尤其在老年人口中。那么微循環與慢性疾病之間的關聯是什么?微循環障礙的原因是什么?在當今慢性病盛行的時代,這都需要密切關注,并深入研究。

基于此,梅奧診所研究人員的試驗結果顯示,Bioboosti 可以改善微循環,使受損微循環逐漸正常化,從而改善多種慢性疾病。

Mayo Clinic
百慕迪 (上海) 再生醫學科技有限公司